Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28014698 | 0.87 | CYP1A2 (0.45) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL9721444 | 0.84 | LMNA (0.40) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL30472794 | 0.82 | LMNA (0.45) | LMNASLC6A6CYP2C19BLMCYP1A2 | |
| SCHEMBL8316075 | 0.82 | CYP1A2 (0.37) | LMNACYP1A2 | |
| SCHEMBL16431281 | 0.82 | LMNA (0.32) | LMNASLC6A6CYP2C19BLM | |
| SCHEMBL22717119 | 0.81 | DGKA (0.44) | LMNACYP1A2 | |
| SCHEMBL31051576 | 0.79 | DGKA (0.47) | LMNA | |
| SCHEMBL6578152 | 0.79 | CES2 (0.41) | LMNA | |
| SCHEMBL5156066 | 0.79 | DGKA (0.47) | LMNA | |
| SCHEMBL29606730 | 0.79 | DGKA (0.43) | LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999042097-A1 | SMALL MOLECULES THAT ELICIT A POLARIZED TH1 RESPONSE AND FOR MODULATION OF CELLULAR IMMUNITY | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | claimed |
| US-20240041802-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | AXON CONNECTED, LLC | 2024-02-08 | — | — | US | disclosed |
| US-11672771-B2 | Beta-alethine, immune modulators, and uses thereof | AXIMMUNE, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-20200069616-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | AXON CONNECTED, LLC | 2020-03-05 | — | — | US | disclosed |
| EP-3534933-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | Aximmune, Inc. (US) | 2019-09-11 | — | — | EP | disclosed |
| US-20090136546-A1 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2009-05-28 | — | — | US | disclosed |
| US-20080248067-A1 | Immunomodulating Compositions and Uses Therefor | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-10-09 | — | — | US | disclosed |
| EP-1874348-A1 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006108241-A1 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-10-19 | — | — | WO | disclosed |
| US-7071232-B1 | Small molecules that increase the conversion of food to body weight gain | DOVETAIL TECHNOLOGIES INC. | 2006-07-04 | — | — | US | disclosed |
| US-6451853-B1 | Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity | DOVETAIL TECHNOLOGIES, INC | 2002-09-17 | — | — | US | disclosed |
| US-6414114-B2 | USEFUL AS AGENTS IN OXIDATION-REDUCTION EQUILIBRIUM IN CELLS; ENZYME REGULATION IN HOMEOSTASIS | DOVETAIL TECHNOLOGIES, INC. | 2002-07-02 | — | — | US | disclosed |
| US-20010008933-A1 | NOVEL DISULFIDES AND THIOL COMPOUNDS | DOVETAIL TECHNOLOGIES INC. | 2001-07-19 | — | — | US | disclosed |
| WO-2001002013-A1 | PREDICTING IMMUNOTHERAPY EFFECTIVENESS THROUGH DELAYED TYPE HYPERSENSITIVITY | LIFETIME PHARMACEUTICALS, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-1056770-A1 | NOVEL DISULFIDES AND THIOL COMPOUNDS | Dovetail Technologies, Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999042097-A1 | SMALL MOLECULES THAT ELICIT A POLARIZED TH1 RESPONSE AND FOR MODULATION OF CELLULAR IMMUNITY | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999042116-A1 | NOVEL DISULFIDES AND THIOL COMPOUNDS | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010008933-A1 | NOVEL DISULFIDES AND THIOL COMPOUNDS | CBS, CSTB, SCLY | LMNA 4805/4885SLC6A6 1473/4885CYP2C19 2881/4885 |
| US-11672771-B2 | Beta-alethine, immune modulators, and uses thereof | CD58, FUT4, FUT8 | LMNA 3384/4885SLC6A6 2763/4885CYP2C19 4361/4885 |
| US-20240041802-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | CD58, FUT4, FUT8 | LMNA 3384/4885SLC6A6 2763/4885CYP2C19 4361/4885 |
| US-20200069616-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | CD58, FUT4, FUT8 | LMNA 3384/4885SLC6A6 2763/4885CYP2C19 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.